+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Carbetocin Market - Global Forecast 2026-2032- Product Image
Carbetocin Market - Global Forecast 2026-2032- Product Image
Sale

Carbetocin Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010691
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Carbetocin Market is projected to reach USD 240.24 Million in 2026. It is expected to continue growing at a CAGR of 6.92%, reaching USD 359.05 Million by 2032.

Carbetocin Market Executive Summary: Clinical Role and Strategic Context

Carbetocin is a long-acting oxytocin analogue used to support uterine contraction and reduce the risk of postpartum haemorrhage, particularly after childbirth. Its strategic relevance is shaped by maternal-health priorities, facility-based delivery practices, medicine procurement systems, regulatory requirements, and the need for dependable obstetric care. Adoption decisions commonly depend on clinical guidelines, approved indications, storage and administration requirements, health-worker training, and product quality assurance.

How Maternal-Health Priorities Are Reshaping Carbetocin Use

The landscape is shifting toward prevention of postpartum haemorrhage through standardized protocols, earlier risk identification, and stronger integration of medicines into emergency obstetric systems. Health authorities and providers are also placing greater emphasis on quality-assured products, supply continuity, pharmacovigilance, and alignment with national treatment guidelines. These changes favor stakeholders that can demonstrate appropriate clinical use, reliable distribution, and practical implementation across both tertiary hospitals and lower-resource maternity settings.

Artificial Intelligence’s Cumulative Impact on Carbetocin Delivery

Artificial intelligence can strengthen the systems surrounding carbetocin rather than replace clinical judgment. Potential applications include identifying patients at elevated haemorrhage risk from structured records, supporting inventory and cold-chain monitoring, detecting unusual procurement patterns, and improving post-market safety-signal review. Benefits will depend on representative data, validated clinical workflows, privacy safeguards, transparent model performance, and clear accountability. AI should therefore be deployed as decision support within established obstetric protocols, with clinicians retaining responsibility for treatment decisions.

Regional Insights: Uneven Access and Differing Implementation Priorities

North America is characterized by mature hospital systems, detailed obstetric protocols, and rigorous regulatory and pharmacovigilance expectations. Latin America is likely to prioritize affordability, public procurement, and consistent access across urban and rural maternity services. Europe places strong emphasis on evidence-based guidelines, product quality, and coordinated health-system implementation. The Middle East combines advanced referral hospitals with varied access across health systems, making workforce capability and procurement coordination important. Africa faces substantial variation in facility readiness, medicine availability, and skilled birth attendance, increasing the value of scalable prevention protocols. Asia-Pacific spans highly developed systems and resource-constrained settings, creating demand for context-specific implementation, reliable supply, and training.

Group Insights: Policy Alignment Across Major Economic and Security Blocs

ASEAN members may benefit from harmonized maternal-health practices, shared procurement learning, and stronger cross-border quality standards. BRICS countries represent diverse regulatory and health-system environments, so implementation strategies should account for domestic manufacturing capacity, public-sector purchasing, and differences in facility access. The European Union supports coordinated regulatory principles and guideline alignment while retaining national reimbursement and service-delivery differences. G7 systems generally emphasize robust evidence, safety monitoring, and integrated hospital governance. GCC countries often combine centralized purchasing with advanced referral infrastructure, while workforce localization and protocol consistency remain relevant. NATO members have an additional interest in resilient medical supply chains and continuity of essential obstetric services during emergencies.

Country Insights: Distinct Regulatory and Health-System Considerations

Australia and Canada emphasize guideline-based maternity care, regulatory compliance, and equitable access across geographically dispersed communities. Brazil and Mexico must balance public-sector procurement with regional disparities in maternal services. China and India require approaches suited to large and diverse health systems, including differences between major hospitals and lower-resource facilities. France, Germany, Italy, Spain, and the United Kingdom operate within tightly governed clinical and medicine-regulation environments, with implementation influenced by national guidance and hospital formularies. Japan and South Korea place strong emphasis on quality assurance, specialist care, and aging or highly developed health infrastructure. Russia’s implementation context is shaped by national procurement, domestic regulatory processes, and geographic distribution challenges. Across the United States, hospital protocols, payer considerations, regulatory requirements, and variation in maternity-care access are central factors.

Action Priorities for Leaders Strengthening Carbetocin Access and Use

Industry leaders should align product positioning with authoritative maternal-health guidance and clearly define appropriate clinical use. They should invest in quality systems, resilient sourcing, temperature-control assurance where applicable, traceability, and pharmacovigilance. Partnerships with ministries, hospitals, professional societies, and humanitarian organizations can improve protocol adoption and health-worker training. Evidence generation should focus on real-world implementation, patient selection, comparative clinical practice, and outcomes relevant to diverse care settings. Digital tools, including AI, should be introduced through controlled pilots with clinical validation, cybersecurity protections, and measurable operational outcomes. Regional strategies should be adapted to procurement rules, regulatory pathways, reimbursement structures, and facility capabilities rather than applied uniformly.

Research Methodology: Evidence-Based Interpretation of the Carbetocin Landscape

This executive summary uses the supplied market reference only to identify the subject area and applies a qualitative, evidence-based framework to assess clinical, regulatory, operational, regional, group, and country considerations. The analysis draws on established principles of maternal-health delivery, medicine governance, pharmacovigilance, procurement resilience, and responsible digital-health adoption. It intentionally excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims. Regional, group, and country observations are presented as contextual interpretations and should be validated against current national guidelines, regulatory decisions, procurement records, and facility-level evidence before investment or policy action.

Conclusion: Execution Quality Will Determine Carbetocin’s Clinical Value

Carbetocin’s impact depends less on product availability alone than on appropriate patient selection, trained personnel, dependable supply, quality assurance, and integration into postpartum-haemorrhage prevention protocols. Regional and national differences require locally adapted implementation plans, while AI can improve risk identification, logistics, and safety monitoring when governed responsibly. Leaders who combine clinical evidence with resilient operations, regulatory discipline, and equitable access strategies will be best positioned to support effective maternal-health outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Carbetocin Market, by Indication
7.1. Introduction
7.2. Prevention Of Postpartum Hemorrhage
7.2.1. Cesarean Section
7.2.2. Vaginal Delivery
7.3. Treatment Of Postpartum Hemorrhage
7.3.1. Cesarean Section
7.3.2. Vaginal Delivery
8. Carbetocin Market, by Formulation
8.1. Introduction
8.2. Prefilled Syringe
8.3. Vial
9. Carbetocin Market, by Route Of Administration
9.1. Introduction
9.2. Intramuscular
9.3. Intravenous
10. Carbetocin Market, by End User
10.1. Introduction
10.2. Birthing Centers
10.3. Clinics
10.4. Hospitals
11. Carbetocin Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Retail Pharmacies
12. Carbetocin Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Carbetocin Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Carbetocin Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Alembic Pharmaceuticals Limited
16.3. Cipla Limited
16.4. Ferring Pharmaceuticals A/S
16.5. Fresenius Kabi AG
16.6. Gland Pharma Limited
16.7. Intas Pharmaceuticals Limited
16.8. Johnson & Johnson Services, Inc.
16.9. Macleods Pharmaceuticals Pvt. Ltd.
16.10. Merck & Co., Inc.
16.11. Novo Nordisk A/S
16.12. Pfizer Inc.
16.13. Sun Pharmaceutical Industries Limited
16.14. Teva Pharmaceutical Industries Ltd.
16.15. Viatris Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Carbetocin Market, Years Considered for the Study
FIGURE 2. Global Carbetocin Market, Research Design
FIGURE 3. Global Carbetocin Market, Research Framework
FIGURE 4. Global Carbetocin Market, Data Triangulation
FIGURE 5. Global Carbetocin Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Carbetocin Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Carbetocin Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Carbetocin Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 9. Global Carbetocin Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Carbetocin Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Carbetocin Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Carbetocin Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Carbetocin Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Carbetocin Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Carbetocin Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Carbetocin Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Carbetocin Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Carbetocin Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Carbetocin Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Carbetocin Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Carbetocin Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Carbetocin Market Segmentation & Coverage
TABLE 2. Global Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 3. Global Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Prevention Of Postpartum Hemorrhage Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Prevention Of Postpartum Hemorrhage Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Prevention Of Postpartum Hemorrhage Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cesarean Section Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cesarean Section Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cesarean Section Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Vaginal Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Vaginal Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Vaginal Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Treatment Of Postpartum Hemorrhage Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Treatment Of Postpartum Hemorrhage Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Treatment Of Postpartum Hemorrhage Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cesarean Section Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cesarean Section Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cesarean Section Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Vaginal Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Vaginal Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Vaginal Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 23. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 30. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 37. Global Birthing Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Birthing Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Birthing Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 47. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. North America Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. North America Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 64. North America Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 65. North America Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 66. North America Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 67. North America Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 68. North America Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. North America Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 70. Latin America Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Latin America Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 72. Latin America Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 73. Latin America Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 74. Latin America Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 75. Latin America Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 76. Latin America Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Latin America Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Europe Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 80. Europe Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 81. Europe Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 82. Europe Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 83. Europe Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 84. Europe Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Europe Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Middle East Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Middle East Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 88. Middle East Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 89. Middle East Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 90. Middle East Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 91. Middle East Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 92. Middle East Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Middle East Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 94. Africa Carbetocin Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Africa Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 96. Africa Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 97. Africa Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 98. Africa Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 99. Africa Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 100. Africa Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Africa Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. Global Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 105. ASEAN Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 106. ASEAN Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 107. ASEAN Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 108. ASEAN Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 109. ASEAN Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. ASEAN Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. GCC Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. GCC Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 113. GCC Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 114. GCC Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 115. GCC Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 116. GCC Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 117. GCC Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. GCC Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 119. European Union Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. European Union Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 121. European Union Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 122. European Union Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 123. European Union Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 124. European Union Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 125. European Union Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. European Union Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. BRICS Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. BRICS Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 129. BRICS Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 130. BRICS Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 131. BRICS Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 132. BRICS Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 133. BRICS Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. BRICS Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. G7 Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. G7 Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 137. G7 Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 138. G7 Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 139. G7 Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 140. G7 Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 141. G7 Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. NATO Carbetocin Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. NATO Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 145. NATO Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 146. NATO Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 147. NATO Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 148. NATO Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 149. NATO Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. NATO Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. Global Carbetocin Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. United States Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 153. United States Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 154. United States Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 155. United States Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 156. United States Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 157. United States Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. United States Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. United States Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Canada Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 161. Canada Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 162. Canada Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 163. Canada Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 164. Canada Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 165. Canada Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 166. Canada Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Canada Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. Mexico Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 169. Mexico Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 170. Mexico Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 171. Mexico Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 172. Mexico Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 173. Mexico Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 174. Mexico Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Mexico Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Brazil Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 177. Brazil Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 178. Brazil Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 179. Brazil Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 180. Brazil Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 181. Brazil Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 182. Brazil Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Brazil Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. United Kingdom Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 185. United Kingdom Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 186. United Kingdom Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 187. United Kingdom Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 188. United Kingdom Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 189. United Kingdom Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. United Kingdom Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. United Kingdom Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. Germany Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 193. Germany Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 194. Germany Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 195. Germany Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 196. Germany Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 197. Germany Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 198. Germany Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Germany Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. France Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 201. France Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 202. France Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 203. France Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 204. France Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 205. France Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 206. France Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. France Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Russia Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 209. Russia Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 210. Russia Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 211. Russia Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 212. Russia Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 213. Russia Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 214. Russia Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Russia Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Italy Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 217. Italy Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 218. Italy Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 219. Italy Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 220. Italy Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 221. Italy Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 222. Italy Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Italy Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Spain Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 225. Spain Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 226. Spain Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 227. Spain Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 228. Spain Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 229. Spain Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 230. Spain Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Spain Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. China Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 233. China Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 234. China Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 235. China Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 236. China Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 237. China Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 238. China Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. China Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. India Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 241. India Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 242. India Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 243. India Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 244. India Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 245. India Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 246. India Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. India Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. Japan Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 249. Japan Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 250. Japan Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 251. Japan Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 252. Japan Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 253. Japan Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 254. Japan Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Japan Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Australia Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 257. Australia Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 258. Australia Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 259. Australia Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 260. Australia Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 261. Australia Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 262. Australia Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Australia Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. South Korea Carbetocin Market Size, 2017-2032 (USD Million)
TABLE 265. South Korea Carbetocin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 266. South Korea Carbetocin Market Size, by Prevention Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 267. South Korea Carbetocin Market Size, by Treatment Of Postpartum Hemorrhage, 2017-2032 (USD Million)
TABLE 268. South Korea Carbetocin Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 269. South Korea Carbetocin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 270. South Korea Carbetocin Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. South Korea Carbetocin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 272. Global Carbetocin Market Share, by Key Player, 2025
TABLE 273. Global Carbetocin Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Alembic Pharmaceuticals Limited
  • Cipla Limited
  • Ferring Pharmaceuticals A/S
  • Fresenius Kabi AG
  • Gland Pharma Limited
  • Intas Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Macleods Pharmaceuticals Pvt. Ltd.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 240.24 Million
Forecasted Market Value ( USD ) by 2032 $ 359.05 Million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Carbetocin for Injection Market - Global Forecast 2026-2032 - Product Image

Carbetocin for Injection Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Carbetocin API Market - Global Forecast 2026-2032 - Product Image

Carbetocin API Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Oxytocic Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Oxytocic Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Oxytocin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Oxytocin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Carboprost Tromethamine - Global Strategic Business Report - Product Image

Carboprost Tromethamine - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From

About the Carbetocin Market

Carbetocin is a synthetic oxytocin analogue used in the treatment of postpartum haemorrhage (PPH). It is a drug used in the field of Sexual and Reproductive Health (SRH) and is administered intravenously or intramuscularly. Carbetocin is used to reduce the risk of PPH, a major cause of maternal mortality and morbidity. It is also used to reduce the need for additional uterotonics and to reduce the risk of uterine atony. Carbetocin has been shown to be more effective than oxytocin in preventing PPH and has fewer side effects. Carbetocin is available in many countries, including the United States, Canada, Australia, and the United Kingdom. It is approved for use in the treatment of PPH in the United States and Canada. Some companies in the Carbetocin market include Ferring Pharmaceuticals, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.